By Professor David Dang Fung Ma

Book Chapters

Ma DD; Gluckman A; Niederwieser A; Aljurf A, 2017, 'HSCT Center’s Success is Dependent upon Adequate Staff Education and Training', in Gluckman E; Niederwieser D; Aljurf M (ed.), Establishing a Hematopoietic Stem Cell Transplantation: A Practical Guide, Springer, pp. 271 - 279, http://dx.doi.org/10.1007/978-3-319-59358-6_19

Tao H; Khoo ML; Shen B; Ma DD, 2007, 'Expression of Neurofilament Proteins in Adult Bone Marrow Mesenchymal Stem Cells and Embryonic Stem Cells and Their Clinical Potential', in Davenport LP (ed.), Stem Cell Research Advances, Nova Science Publishers

Journal articles

Penglase R; Girgis L; Englert H; Ma D; Moore J, 2024, 'Australian rheumatologists' perception of autologous haemopoietic stem cell transplantation for the treatment of systemic sclerosis: a cross-sectional survey', Internal Medicine Journal, 54, pp. 1478 - 1482, http://dx.doi.org/10.1111/imj.16422

Hashmi SK; Powles RC; Ma D; Muhsen IN; Aljurf M; Niederwieser D; Weisdorf DJ; Koh MBC; Greinix H, 2024, 'Radiation hazards of the Ukraine nuclear power plants: how can international blood and marrow stem cell transplant societies help?', Annals of Hematology, 103, pp. 1121 - 1129, http://dx.doi.org/10.1007/s00277-023-05191-9

Moore J; Milliken S; Dodds A; Ma D; Snowden J, 2024, 'James Crawford Biggs 1931-2023', Bone marrow transplantation, 59, pp. 291 - 292, http://dx.doi.org/10.1038/s41409-023-02170-6

Massey J; Visweswaran M; Khoo M; Hendrawan K; Sutton I; Withers B; Ma D; Moore J, 2023, 'Detailed immunophenotyping of the hematopoietic graft from patients with multiple sclerosis undergoing autologous hematopoietic stem cell transplant', Cytotherapy, 25, pp. 1271 - 1276, http://dx.doi.org/10.1016/j.jcyt.2023.08.010

Blennerhassett R; Othman J; Biscoe A; Kliman D; Mills G; Blyth E; Micklethwaite K; Kwan J; Bilmon I; Bhattacharyya A; Panicker S; Fay K; Milliken S; Ma D; Hamad N; Stevenson W; Arthur C; Moore J; Greenwood M; Gottlieb D; Kerridge I, 2023, 'Long-term outcomes of corticosteroid graft versus host disease prophylaxis in peripheral blood allogeneic haemopoietic stem cell transplant: a comparative cohort analysis', Internal Medicine Journal, 53, pp. 1979 - 1986, http://dx.doi.org/10.1111/imj.16043

Massey J; Artuz C; Dyer Z; Jackson K; Khoo M; Visweswaran M; Withers B; Moore J; Ma D; Sutton I, 2023, 'Diversification and expansion of the EBV-reactive cytotoxic T lymphocyte repertoire following autologous haematopoietic stem cell transplant for multiple sclerosis', Clinical Immunology, 254, http://dx.doi.org/10.1016/j.clim.2023.109709

Penglase R; Girgis L; Englert H; Brennan X; Jabbour A; Kotlyar E; Ma D; Moore J, 2023, 'Cardiotoxicity in autologous haematopoietic stem cell transplantation for systemic sclerosis', Journal of Scleroderma and Related Disorders, 8, pp. 87 - 100, http://dx.doi.org/10.1177/23971983221145639

Moles E; Howard CB; Huda P; Karsa M; McCalmont H; Kimpton K; Duly A; Chen Y; Huang Y; Tursky ML; Ma D; Bustamante S; Pickford R; Connerty P; Omari S; Jolly CJ; Joshi S; Shen S; Pimanda JE; Dolnikov A; Cheung LC; Kotecha RS; Norris MD; Haber M; de Bock CE; Somers K; Lock RB; Thurecht KJ; Kavallaris M; Moles Meler E, 2023, 'Delivery of PEGylated liposomal doxorubicin by bispecific antibodies improves treatment in models of high-risk childhood leukemia', Science translational medicine, 15, pp. eabm1262 - eabm1262, http://dx.doi.org/10.1126/scitranslmed.abm1262

Ma DDF; Fennessy K; Kliman D, 2022, 'Potential benefits of a virtual, home-based combined exercise and mindfulness training program for HSC transplant survivors: a single-arm pilot study', BMC Sports Science, Medicine and Rehabilitation, 14, http://dx.doi.org/10.1186/s13102-022-00554-7

Brennan X; Withers B; Jabbour A; Milliken S; Kotlyar E; Fay K; Ma D; Muthiah K; Hamad N; Dodds A; Bart N; Keogh A; Hayward C; Macdonald P; Moore J, 2022, 'Efficacy of bortezomib, cyclophosphamide and dexamethasone in cardiac AL amyloidosis', Internal Medicine Journal, 52, pp. 1826 - 1830, http://dx.doi.org/10.1111/imj.15926

Achini-Gutzwiller FR; Snowden JA; Corbacioglu S; Greco R; Alexander T; Badoglio M; Labopin M; Abinun M; Apte S; Arnold R; Domenech A; Brierley C; Burman J; Castilla-Llorente C; Cooper N; Daghia G; Daikeler T; del Papa N; de Vries-Bouwstra J; Farge D; Finke J; Hagglund H; Hawkey C; Henes J; Hiepe F; Jessop H; Kiely D; Kazmi M; Kirgizov K; Kramer E; Mancardi G; Marjanovic Z; Martin R; Martin T; Ma D; Moore J; Miller P; Muraro P; Oliveira MC; Polushin A; Onida F; Simoes B; Puyade M; Resnick I; Ricart E; Rovira M; Saccardi R; Saif M; Sakellari I; Sharrack B; Snarski E; Scherer HU; Sossa C; Withers B; Wulffraat N; Zaccara E; Amrolia P; Ansari M; Balduzzi A; Dalassier A; Dalle JH; Diaz CH; Feuchtinger T; Locatelli F; Lucchini G; Galimard JE; Vincent MG; Handgretinger R; Kleinschmidt K; Lawitschka A; Martinez AP; Peters C; Rocha V; Ruggeri A; Sedlacek P; Svec P; Toporski J; Yesilipek A, 2022, 'Haematopoietic stem cell transplantation for severe autoimmune diseases in children: A review of current literature, registry activity and future directions on behalf of the autoimmune diseases and paediatric diseases working parties of the European Society for Blood and Marrow Transplantation', British Journal of Haematology, 198, pp. 24 - 45, http://dx.doi.org/10.1111/bjh.18176

Penglase R; Englert H; Tymms K; Carr A; Ma D; Milliken S; Moore J, 2022, 'Successful lymphoablative autologous haematopoietic stem cell transplantation in three cases of severe autoimmune disease despite reduced dose cyclophosphamide conditioning—do we need 200 mg/kg cyclophosphamide?', Bone Marrow Transplantation, 57, pp. 1207 - 1209, http://dx.doi.org/10.1038/s41409-022-01696-5

Chang A; Ragg SJ; Ma DD, 2022, 'Meeting the COVID challenge: Optimizing vCD34⁺ in cryopreserved HPC samples for implementation of an external QA Program', Cytotherapy, 24, pp. 437 - 443, http://dx.doi.org/10.1016/j.jcyt.2021.10.009

Massey J; Jackson K; Singh M; Hughes B; Withers B; Ford C; Khoo M; Hendrawan K; Zaunders J; Charmeteau-De Muylder B; Cheynier R; Luciani F; Ma D; Moore J; Sutton I, 2022, 'Haematopoietic Stem Cell Transplantation Results in Extensive Remodelling of the Clonal T Cell Repertoire in Multiple Sclerosis', Frontiers in Immunology, 13, http://dx.doi.org/10.3389/fimmu.2022.798300

Visweswaran M; Hendrawan K; Massey JC; Khoo ML; Ford CD; Zaunders JJ; Withers B; Sutton IJ; Ma DDF; Moore JJ, 2022, 'Sustained immunotolerance in multiple sclerosis after stem cell transplant', Annals of Clinical and Translational Neurology, 9, pp. 206 - 220, http://dx.doi.org/10.1002/acn3.51510

Hendrawan K; Khoo MLM; Visweswaran M; Massey JC; Withers B; Sutton I; Ma DDF; Moore JJ, 2022, 'Long-Term Suppression of Circulating Proinflammatory Cytokines in Multiple Sclerosis Patients Following Autologous Haematopoietic Stem Cell Transplantation', Frontiers in Immunology, 12, http://dx.doi.org/10.3389/fimmu.2021.782935

Nivison-Smith I; Bajel A; Dodds AJ; Gottlieb D; Hamad N; Kennedy G; Kerridge I; Ma DDF; Milliken S; Moore J; Purtill D; Szer J, 2022, 'Effect of donor age on adult unrelated donor haemopoietic cell transplant outcome: the Australian experience', Internal Medicine Journal, 52, pp. 57 - 62, http://dx.doi.org/10.1111/imj.15128

Purtill D; Hutchins C; Kennedy G; McClean A; Fraser C; Shaw PJ; Chiappini P; Tao H; Ma DD; Kabani K; Bai L; Greenwood M; Bajel A; O'Flaherty E; Curtis DJ; Purins L; Perera T; Tan S; Butler A; Micklethwaite K; Antonenas V; Gottlieb D; Hamad N, 2021, 'Good Engraftment but Quality and Donor Concerns for Cryopreserved Hemopoietic Progenitor Cell Products Collected During the COVID-19 Pandemic', Transplantation and Cellular Therapy, 27, pp. 1022.e1 - 1022.e6, http://dx.doi.org/10.1016/j.jtct.2021.09.012

Perram J; Mayson E; Tang C; Tran S; Aarons D; Dodds AJ; Fay K; Hamad N; Ma D; Milliken S; Withers B; Greenwood M; Stevenson WS; Arthur CK; Kerridge IH; Moore J, 2021, 'Outcomes for Allogeneic Stem Cell Transplantation in Secondary AML Are Inferior to De Novo AML and Are Independent of the Disease Risk Index', BLOOD, 138, http://dx.doi.org/10.1182/blood-2021-147106

Chatterton S; Withers B; Sutton IJ; Milliken ST; Ma DDF; Moore JJ; Massey JC, 2021, 'Pregnancy post autologous stem cell transplant with BEAM conditioning for multiple sclerosis', Multiple Sclerosis Journal, 27, pp. 2112 - 2115, http://dx.doi.org/10.1177/13524585211005660

Damodar S; Ma DD; Ragg SJ; Chang A; Hwang WY; Ho AY; Srivastava A, 2021, 'Standardization and Accreditation in Haemopoietic Stem Cell Transplantation - an Asia Pacific Perspective.', Blood Cell Ther, 4, pp. S14 - S19, http://dx.doi.org/10.31547/bct-2021-015

Vu TT; Stölzel F; Wang KW; Röllig C; Tursky ML; Molloy TJ; Ma DD, 2021, 'miR-10a as a therapeutic target and predictive biomarker for MDM2 inhibition in acute myeloid leukemia', Leukemia, 35, pp. 1933 - 1948, http://dx.doi.org/10.1038/s41375-020-01095-z

Puyade M; Patel A; Lim YJ; Blank N; Badoglio M; Gualandi F; Ma DD; Maximova N; Greco R; Alexander T; Snowden JA, 2021, 'Autologous Hematopoietic Stem Cell Transplantation for Behçet’s Disease: A Retrospective Survey of Patients Treated in Europe, on Behalf of the Autoimmune Diseases Working Party of the European Society for Blood and Marrow Transplantation', Frontiers in Immunology, 12, http://dx.doi.org/10.3389/fimmu.2021.638709

McCaughan G; Ma D; Moore J, 2021, 'Two cases of successful autologous stem cell transplantation in patients with multiple myeloma and concurrent chronic myeloid leukaemia', Bone Marrow Transplantation, 56, pp. 514 - 516, http://dx.doi.org/10.1038/s41409-020-01025-8

Yeola A; Subramanian S; Oliver RA; Lucas CA; Thoms JAI; Yan F; Olivier J; Chacon D; Tursky ML; Srivastava P; Potas JR; Hung T; Power C; Hardy P; Ma DD; Kilian KA; McCarroll J; Kavallaris M; Hesson LB; Beck D; Curtis DJ; Wong JWH; Hardeman EC; Walsh WR; Mobbs R; Chandrakanthan V; Pimanda JE; Subramanian S, 2021, 'Induction of muscle-regenerative multipotent stem cells from human adipocytes by PDGF-AB and 5-azacytidine', Science Advances, 7, pp. eabd1929, http://dx.doi.org/10.1126/sciadv.abd1929

Snowden JA; Styczyński J; Snarski E; Greco R; Badoglio M; Labopin M; Abinun M; Apte S; Arnold R; Boglione C; Brierley C; Burman J; Castilla-Llorente C; Cooper N; Daghia G; Daikeler T; del Papa N; de Vries-Bouwstra J; Farge D; Finke J; Hagglund H; Hawkey C; Henes J; Hiepe F; Jessop H; Kiely D; Kazmi M; Kirgizov K; Kramer E; Mancardi G; Marjanovic Z; Martin R; Martin T; Ma D; Moore J; Miller P; Muraro P; Oliveira MC; Polushin A; Onida F; Simoes B; Puyade M; Resnick I; Ricart E; Rovira M; Saccardi R; Saif M; Sakellari I; Sharrack B; Scherer HU; Sossa C; Withers B; Wulffraat N; Zaccara E, 2021, 'Hematopoietic stem cell transplantation in autoimmune diseases: update from the EBMT Autoimmune Diseases Working Party with special reference to Poland', Acta Haematologica Polonica, 52, pp. 217 - 224, http://dx.doi.org/10.5603/AHP.2021.0043

Othman J; Greenwood M; Moore J; Larsen S; Watson AM; Arthur C; Bhattacharyya A; Bilmon I; Blyth E; Bryant A; Bryant C; Dunlop L; Fay K; Gibson J; Hamad N; Kerridge I; Kwan J; Ma D; Micklethwaite K; Milliken S; Panicker S; Stevenson W; Withers B; Wilcox L; Tran S; Gottlieb DJ, 2020, 'Unrelated Donor Transplant Recipients Given Thymoglobuline Have Superior GRFS When Compared to Matched Related Donor Recipients Undergoing Transplantation without ATG', Biology of Blood and Marrow Transplantation, 26, pp. 1868 - 1875, http://dx.doi.org/10.1016/j.bbmt.2020.06.030

Tursky ML; Loi TH; Artuz CM; Alateeq S; Wolvetang EJ; Tao H; Ma DD; Molloy TJ, 2020, 'Direct Comparison of Four Hematopoietic Differentiation Methods from Human Induced Pluripotent Stem Cells', Stem Cell Reports, 15, pp. 735 - 748, http://dx.doi.org/10.1016/j.stemcr.2020.07.009

Kliman D; Nivison-Smith I; Gottlieb D; Hamad N; Kerridge I; Purtill D; Szer J; Ma D, 2020, 'Hematopoietic Stem Cell Transplant Recipients Surviving at Least 2 Years from Transplant Have Survival Rates Approaching Population Levels in the Modern Era of Transplantation', Biology of Blood and Marrow Transplantation, 26, pp. 1711 - 1718, http://dx.doi.org/10.1016/j.bbmt.2020.03.005

Hendrawan K; Visweswaran M; Ma DDF; Moore JJ, 2020, 'Tolerance regeneration by T regulatory cells in autologous haematopoietic stem cell transplantation for autoimmune diseases', Bone Marrow Transplantation, 55, pp. 857 - 866, http://dx.doi.org/10.1038/s41409-019-0710-2

Sharrack B; Saccardi R; Alexander T; Badoglio M; Burman J; Farge D; Greco R; Jessop H; Kazmi M; Kirgizov K; Labopin M; Mancardi G; Martin R; Moore J; Muraro PA; Rovira M; Sormani MP; Snowden JA; McGrath E; Bambi F; Sanchez-Guijo F; Worel N; Badolglio M; Abinun M; Arnold R; Brierley C; Castilla-Llorente C; Cooper N; Daikeler T; del Papa N; Finke J; Reax R; Hagglund H; Henes J; Hiepe F; Kiely D; Mancardi G; Marjanovic Z; Martin T; Ma D; Miller P; Oliveira MC; Polushin A; Onida F; Simoes B; Puyade M; Resnick I; Saif M; Sakellari I; Snarski E; Scherer HU; Sossa C; de Vries-Bouwstra J; Wulffraat N; Zaccara E, 2020, 'Autologous haematopoietic stem cell transplantation and other cellular therapy in multiple sclerosis and immune-mediated neurological diseases: updated guidelines and recommendations from the EBMT Autoimmune Diseases Working Party (ADWP) and the Joint Accreditation Committee of EBMT and ISCT (JACIE)', Bone Marrow Transplantation, 55, pp. 283 - 306, http://dx.doi.org/10.1038/s41409-019-0684-0

Kliman DS; Kotecha SR; Abelson DC; Snell GI; Glanville AR; Ma DDF, 2019, 'Favorable Outcome of Lung Transplantation for Severe Pulmonary Graft Versus Host Disease: An Australian Multicenter Case Series', Transplantation, 103, pp. 2602 - 2607, http://dx.doi.org/10.1097/TP.0000000000002693

Moore JJ; Massey JC; Ford CD; Khoo ML; Zaunders JJ; Hendrawan K; Barnett Y; Barnett MH; Kyle KA; Zivadinov R; Ma KC; Milliken ST; Sutton IJ; Ma DDF, 2019, 'Prospective phase II clinical trial of autologous haematopoietic stem cell transplant for treatment refractory multiple sclerosis', Journal of Neurology, Neurosurgery and Psychiatry, 90, pp. 514 - 521, http://dx.doi.org/10.1136/jnnp-2018-319446

Younes A; Brody J; Carpio C; Lopez-Guillermo A; Ben-Yehuda D; Ferhanoglu B; Nagler A; Ozcan M; Avivi I; Bosch F; Caballero Barrigón MD; Hellmann A; Kuss B; Ma DDF; Demirkan F; Yağci M; Horowitz NA; Marlton P; Cordoba R; Wrobel T; Buglio D; Streit M; Hodkinson BP; Schaffer M; Alvarez J; Ceulemans R; Balasubramanian S; de Jong J; Wang SS; Fourneau N; Jurczak W, 2019, 'Safety and activity of ibrutinib in combination with nivolumab in patients with relapsed non-Hodgkin lymphoma or chronic lymphocytic leukaemia: a phase 1/2a study', The Lancet Haematology, 6, pp. e67 - e78, http://dx.doi.org/10.1016/S2352-3026(18)30217-5

Ma CKK; García-Cadenas I; Fox ML; Ai S; Nivison-Smith I; Milliken ST; Dodds A; Fay K; Ma DDF; Martino R; Sierra J; Moore J, 2018, 'Poor prognosis in patients with steroid refractory acute graft versus host disease treated with etanercept: a multi-centre analysis', Bone Marrow Transplantation, 53, pp. 1478 - 1482, http://dx.doi.org/10.1038/s41409-018-0215-4

Ting YS; Smith SABC; Brown DA; Dodds AJ; Fay KC; Ma DDF; Milliken S; Moore JJ; Sewell WA, 2018, 'CD200 is a useful diagnostic marker for identifying atypical chronic lymphocytic leukemia by flow cytometry', International Journal of Laboratory Hematology, 40, pp. 533 - 539, http://dx.doi.org/10.1111/ijlh.12857

Massey JC; Sutton IJ; Ma DDF; Moore JJ, 2018, 'Regenerating immunotolerance in multiple sclerosis with autologous hematopoietic stem cell transplant', Frontiers in Immunology, 9, http://dx.doi.org/10.3389/fimmu.2018.00410

Nivison-Smith I; Milliken S; Dodds AJ; Gottlieb D; Kwan J; Ma DDF; Shaw PJ; Tran S; Wilcox L; Szer J, 2018, 'Activity and Capacity Profile of Transplant Physicians and Centers in Australia and New Zealand', Biology of Blood and Marrow Transplantation, 24, pp. 169 - 174, http://dx.doi.org/10.1016/j.bbmt.2017.09.011

Ma CKK; Danta M; Day R; Ma DDF, 2018, 'Dealing with the spiralling price of medicines: issues and solutions', Internal Medicine Journal, 48, pp. 16 - 24, http://dx.doi.org/10.1111/imj.13652

Abeysinghe P; Morawaka L; Gunasekara S; Suresh S; Udara PHSP; Siriwardena PPR; Milliken S; Ma DDF; Moore J, 2018, 'Working together: Establishment of the first national hematopoietic stem cell transplantation (HSCT) center in Sri Lanka', Blood Advances, 2, pp. 46 - 49, http://dx.doi.org/10.1182/bloodadvances.2018GS110686

Nivison-Smith I; Milliken S; Dodds A; Gottlieb D; Kwan J; Ma D; Shaw PJ; Tran S; Wilcox L; Szer J, 2018, 'Activity and Capacity Profile of Transplant Physicians and Centres in Australia and New Zealand', Biology of Blood and Marrow Transplantation, 24, pp. S310 - S311, http://dx.doi.org/10.1016/j.bbmt.2017.12.319

Gyi AA; Mra R; Nyein HL; Aung T; Win N; Khin PT; Issaragrisil S; Srivastava A; Ma D; Koh M, 2017, 'Where there's a will, there's a way: Establishing hematopoietic stem cell transplantation in Myanmar', Blood Advances, 1, pp. 65 - 69, http://dx.doi.org/10.1182/bloodadvances.2017GS101637

Van Den Neste E; Schmitz N; Mounier N; Gill D; Linch D; Trneny M; Bouadballah R; Radford J; Bargetzi M; Ribrag V; Dührsen U; Ma D; Briere J; Thieblemont C; Bachy E; Moskowitz CH; Glass B; Gisselbrecht C, 2017, 'Outcomes of diffuse large B-cell lymphoma patients relapsing after autologous stem cell transplantation: An analysis of patients included in the CORAL study', Bone Marrow Transplantation, 52, pp. 216 - 221, http://dx.doi.org/10.1038/bmt.2016.213

Patton WN; Nivison-Smith I; Bardy P; Dodds A; Ma D; Shaw PJ; Kwan J; Wilcox L; Butler A; Carter JM; Blacklock H; Szer J, 2017, 'Graft Transit Time Has No Effect on Outcome of Unrelated Donor Hematopoietic Cell Transplants Performed in Australia and New Zealand: A Study from the Australasian Bone Marrow Transplant Recipient Registry', Biology of Blood and Marrow Transplantation, 23, pp. 147 - 152, http://dx.doi.org/10.1016/j.bbmt.2016.09.026

Molloy TJ; Vu TT; Stölzel F; Ehninger G; Ma D, 2016, 'Mir-10a Regulates Autophagy and Cell Cycle in Normal Karyotype Acute Myeloid Leukaemia', Blood, 128, pp. 2862 - 2862, http://dx.doi.org/10.1182/blood.v128.22.2862.2862

Ma DD; Ma CKK, 2016, 'The spiralling cost of new cancer drugs: What can we do?', SVC Proceedings, 24, pp. 3 - 11, https://stvincentsclinic.com.au/wps/wcm/connect/95cada7c-be3b-4d09-8821-cb1796509509/Proceedings+2016+(3).pdf?MOD=AJPERES&CONVERT_TO=url&CACHEID=95cada7c-be3b-4d09-8821-cb1796509509

Kruger P; Cooney J; Nivison-Smith I; Dodds A; Bardy P; Ma D; Szer J; Durrant S, 2016, 'All is not lost in accelerated phase/blast crisis and after tyrosine kinase inhibitors fail in chronic myeloid leukaemia: A retrospective study of allogeneic stem cell transplant outcomes in Australia and New Zealand', Bone Marrow Transplantation, 51, pp. 1400 - 1403, http://dx.doi.org/10.1038/bmt.2016.143

Cooley-Andrade O; Goh WX; Connor DE; Ma DDF; Parsi K, 2016, 'Detergent Sclerosants Stimulate Leukocyte Apoptosis and Oncosis', European Journal of Vascular and Endovascular Surgery, 51, pp. 846 - 856, http://dx.doi.org/10.1016/j.ejvs.2016.03.008

Back to profile page